Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes

To investigate whether metformin add-on to the continuous subcutaneous insulin infusion (Met + CSII) therapy leads to a significant reduction in insulin doses required by type 2 diabetes (T2D) patients to maintain glycemic control, and an improvement in glycemic variation (GV) compared to CSII only...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng-fei, Liu, Bing-li, Yin, Guo-ping, Yan, Reng-na, Zhang, Dan-feng, Wu, Jin-dan, Ye, Lei, Su, Xiao-fei, Ma, Jian-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018811/
https://www.ncbi.nlm.nih.gov/pubmed/29946148
http://dx.doi.org/10.1038/s41598-018-27950-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018811/
https://www.ncbi.nlm.nih.gov/pubmed/29946148
http://dx.doi.org/10.1038/s41598-018-27950-9

Ejemplares similares